Venolife Duo pills 1000mg, 30pcs

Composition

One tablet contains:

Active ingredient:

Purified micronized flavonoid fraction (in terms of anhydrous substance) containing diosmin (90%) and other flavonoids – 10%) – 500 mg or 1000 mg.

Auxiliary substances:

gelatin,

magnesium stearate,

microcrystalline cellulose,

sodium carboxymethyl starch,

talc.

Film coating: ready-made mixture “Vivacout” [macrogol 6000, titanium dioxide, glycerol, magnesium stearate, hypromellose, iron oxide red dye, iron oxide yellow dye], sodium lauryl sulfate.

Pharmacological action

Pharmacotherapy group: Venotonizing and venoprotective agent.

CodATH: S 05 SA 53

Pharmacological Properties

Pharmacodynamics

The combination of diosmin+hesperidin has venotonizing and angioprotective properties. The drug reduces the dilatability of veins and venous congestion, reduces the permeability of capillaries and increases their resistance. The results of clinical studies confirm the pharmacological activity of the drug in relation to venous hemodynamic parameters. A statistically significant dose-dependent effect of the drug was demonstrated for the following venous plethysmographic parameters: venous capacity, venous extensibility, and time of venous emptying. The optimal dose-effect ratio is observed when taking 1000 mg per day.

The combination of diosmin+hesperidin increases venous tone: venous occlusal plethysmography showed a decrease in the time of venous emptying. In patients with signs of severe microcirculation disorders, after therapy with the drug, an increase in capillary resistance (statistically significant compared to placebo) was observed, evaluated by angiostereometry.

The therapeutic efficacy of the combination of diosmin+hesperidin in the treatment of chronic diseases of the veins of the lower extremities, as well as in the treatment of hemorrhoids, has been proven.

Pharmacokinetics

The main release of the drug occurs with feces. On average, about 14% of the amount of the drug taken is excreted in the urine. The elimination half-life is 11 hours. The drug undergoes an active metabolism, which is confirmed by the presence of phenolic acids in the urine.

Indications

Venolife Duo is indicated for the treatment of symptoms of chronic venous diseases (elimination and relief of symptoms).

Treatment of symptoms of venous-lymphatic insufficiency:

– pain;

– cramps of the lower extremities;

– feeling of heaviness and bursting in the legs;

-” fatigue ” of the legs.

Treatment of venous-lymphatic insufficiency manifestations:

– edema of the lower extremities;

– trophic changes in the skin and subcutaneous tissue;

– venous trophic ulcers.

Symptomatic treatment of acute and chronic hemorrhoids.

Use during pregnancy and lactation

Pregnancy

Animal experiments did not reveal any teratogenic effects. To date, there have been no reports of adverse effects when using the drug in pregnant women.

Breast-feeding

Due to the lack of data on the elimination of the drug in breast milk, lactating women are not recommended to take the drug. Influence on reproductive function. Reproductive toxicity studies have shown no effect on reproductive function in rats of both sexes.

Contraindications

Hypersensitivity to the Active ingredient or to the excipients that make up the drug.

It is not recommended to take the drug for lactating women.

Side effects

Side effects of the diosmin+hesperidin combination observed in clinical trials were mild. Gastrointestinal disorders (diarrhea, dyspepsia, nausea, vomiting) were mainly observed.

The following side effects have been reported when taking the diosmin+hesperidin combination, in the following gradation: very common (≥1/10); common (≥1/100, <1/10); infrequent (≥1/1 000, <1/100); rare (≥1/10 000, <1/1 000); extremely rare(

From the central nervous system:

Rarely: dizziness, headache, general malaise.

From the gastrointestinal tract:

Common: diarrhea, dyspepsia, nausea, vomiting.

Infrequently: colitis.

Unspecified frequency: abdominal pain.

From the side of the skin:

Rare: skin rash, pruritus, urticaria.

Unspecified frequency: isolated swelling of the face, lips, and eyelids.

In exceptional cases, angioedema.

Inform your doctor if you have any adverse reactions, including those not mentioned in these instructions, as well as changes in laboratory parameters during therapy.

Interaction

No clinical studies have been conducted to study the interactions of the diosmin+hesperidin combination with other drugs. To date, no identified cases of drug interactions have been reported.

How to take, course of use and dosage

Inside.

The recommended dose for venous-lymphatic insufficiency is 1000 mg per day, preferably in the morning, with meals. Tablets should be swallowed with water.

The label on the tablet is intended solely for division in order to facilitate ingestion.

The duration of the course of treatment can be several months (up to 12 months). In case of recurrent symptoms, the doctor recommends that the course of treatment be repeated.

The recommended dose for acute hemorrhoids is 3000 mg per day (1000 mg in the morning, afternoon and evening) for 4 days, then 2000 mg per day (1000 mg in the morning and evening) for the next 3 days.

The recommended dose for chronic hemorrhoids is 1000 mg per day.

Overdose

Cases of overdose are not described. If you overdose, seek immediate medical attention.

Special instructions

Before you start taking Venolife Duo, it is recommended to consult your doctor.

In case of acute hemorrhoids, Venolife Duo does not replace the specific treatment of other anal disorders. The duration of treatment should not exceed the time specified in the section “Dosage and use”. In the event that the symptoms do not disappear after the recommended course of therapy, you should be examined by a proctologist, who will select further therapy.

In the presence of venous circulatory disorders, the maximum effect of treatment is provided by combining therapy with a healthy (balanced) lifestyle: it is advisable to avoid long exposure to the sun, prolonged exposure to the feet, and also, it is recommended to reduce excess body weight. Walking and, in some cases, wearing special stockings help to improve blood circulation.

Contact your doctor immediately if your condition worsens or does not improve during treatment.

Influence on the ability to drive vehicles and mechanisms

No clinical studies have been conducted to investigate the effect of the combination of diosmin+hesperidin on the ability to drive a car and perform work that requires a high rate of mental and physical reactions. However, based on the available safety data, it can be concluded that diosmin+hesperidin do not affect (do not have a significant effect) on these processes.

Form of production

Tablets 500 mg or 1000 mg.

10 tablets in a contour cell package made of polyvinyl chloride film and aluminum foil printed varnished.

3 or 6 contour cell packages together with the instructions for use are placed in a pack of cardboard.

Storage conditions

At a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf

life is 2 years.

Active ingredient

Diosmin, flavonoids in terms of hesperidin

Dosage form

Tablets